HOL- TIRZ

HAUS OF LABS

TIRZEPATIDE 15mg

Dual GIP & GLP-1 Receptor Agonist

Tirzepatide is a synthetic peptide-based compound that activates two incretin receptors: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Its dual-receptor activity is what distinguishes tirzepatide from medications that target GLP-1 alone.

How It Works

Tirzepatide activates GIP and GLP-1 receptors involved in metabolic regulation and appetite signalling. Activation of these pathways can influence food intake, insulin secretion and glucagon regulation.

Research and clinical data show that tirzepatide can reduce calorie intake and body weight, with weight reduction generally involving greater loss of fat mass than lean mass.

The molecule is engineered with a fatty-acid component that promotes albumin binding, contributing to its prolonged activity in the body.

Research Areas:

• GIP and GLP-1 receptor signalling
• Appetite and food-intake regulation
• Glucose-dependent insulin secretion
• Glucagon regulation
• Energy and metabolic signalling
• Body-weight regulation

Product: Tirzepatide
Strength: 15mg
Format: Vial

Research use only. Not for human consumption.